DNAprint Genomics (DNAG)

[dgplexus]

Thanks for the link, Ann.

It was easy to see the writing on the wall, even years ago, with these big pharma firms... their blockbuster drugs coming off patent, and their pipelines drying up. That's one reason I decided to invest in companies like DNAPrint Genomics, and Sirtris Pharmaceuticals (which was already bought up by GlaxoSmithKline; I more than doubled my money, on that investment, by buying both shares and call options. I mentioned it over in Yahoo Finance's DNAG board, as another company I'd chosen to invest in, long before the buyout was announced.) Companies like these offer things that these big pharma firms lack, but desperately need. The value doesn't have to come from a buyout, of course. It's just that a piece was/is missing from the big pharma puzzle. They've been needing a change in paradigm, closer to actual biology and genetics.